← Eichor
Condition: Inherited Retinal Disease Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Inherited Retinal Disease

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Natural History of Photoreceptor Degeneration in USH1B: Clinical Parameters and Validation of Functional Vision Tests in
Phase N/A · 1 location(s) · Centre Hospitalier National d'Ophtalmologie des Quinze-Vingt · NCT07278843Systemic Inflammation, Thyroid Autoimmunity and Neuroretinal Changes in Graves Disease
Phase N/A · 1 location(s) · Elazıg Fethi Sekin Sehir Hastanesi · NCT07480720Trilateral Retinoblastoma: Incidence and Outcomes
Phase N/A · 1 location(s) · Amsterdam UMC, location VUmc · NCT06367530Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD
Phase 3 · 181 location(s) · AbbVie · NCT05407636Implementation and Evaluation of a Post-Diagnostic Announcement Protocol at the CRMR RefeRet, Quinze-Vingts Hospital
NA · 1 location(s) · Centre Hospitalier National d'Ophtalmologie des Quinze-Vingt · NCT07292987An Open-label, Dose-ascending Study of IGT001 for Retinitis Pigmentosa
Phase 1 · 1 location(s) · Shanghai General Hospital, Shanghai Jiao Tong University Sch · NCT06936787Progression Assessment of PXE-associated Alterations
Phase N/A · 1 location(s) · University Hospital, Bonn · NCT07048106Study to Evaluate ACDN-01 in ABCA4-related Stargardt Retinopathy (STELLAR)
Phase 1/Phase 2 · 10 location(s) · Ascidian Therapeutics, Inc · NCT06467344Detailed Phenotypic and Genotype Study to Correlate RB1 Mutations Relating to Primary Ocular Tumors and Secondary Extra-
Phase N/A · 1 location(s) · University of Washington · NCT06725173Evaluation of the Frequency, Risk Factors, and Outcomes of ROP in Infants With a BW >1500 Grs or GA ≥33 Wks in Turkey.
Phase N/A · 1 location(s) · Baskent University Ankara Hospital · NCT06265363NYSCF Scientific Discovery Biobank
Phase N/A · 1 location(s) · New York Stem Cell Foundation Research Institute · NCT06203106Safety and Tolerability of Intravitreal Administration of VG901 in Patients With Retinitis Pigmentosa Due to Mutations i
Phase 1 · 1 location(s) · VeonGen Therapeutics GmbH · NCT06291935High Resolution, High-speed Multimodal Ophthalmic Imaging
NA · 1 location(s) · Centre Hospitalier National d'Ophtalmologie des Quinze-Vingt · NCT04129021A Phase II Study of Intravitreal KIO-301 in Patients With Late-stage Retinitis Pigmentosa
Phase 2 · 5 location(s) · Kiora Pharmaceuticals, Inc. · NCT06628947Experimental and Clinical Studies of Retinal Stimulation
NA · 1 location(s) · University of Michigan · NCT03635645AusCADASIL: An Australian Cohort of CADASIL
Phase N/A · 5 location(s) · Perminder Sachdev · NCT06148051Comparing Efficacy of 8-Week and 12-Week Faricimab Initial Follow-Up Treatment Intervals
Phase 4 · 1 location(s) · Faculty Hospital Kralovske Vinohrady · NCT06875245The Effects of Disulfiram (Antabuse®) on Visual Acuity in Patients With Retinal Degeneration
Phase 1 · 1 location(s) · University of Rochester · NCT06319872A Clinical Trial Evaluating the Safety and Efficacy of a New Light Combination Therapy Addressing Intermediate AMD
NA · 1 location(s) · Oculox Technologies SA · NCT06557369Efficacy and Safety Study of Bilateral IVT Injection of GS010 at Two Dose Levels in LHON Patients
Phase 2 · 1 location(s) · GenSight Biologics · NCT07303296Restoration of Central Vision With PRIMA in Patients With Photoreceptor Degeneration
NA · 1 location(s) · Science Corporation · NCT07266584Cell Collection to Study Eye Diseases
Phase N/A · 1 location(s) · National Eye Institute (NEI) · NCT01432847Evaluating the Safety and Tolerability of Orally Administered DF-003 in ROSAH Syndrome Patients
Phase 1 · 5 location(s) · Shanghai Yao Yuan Biotechnology Ltd. (also known as Drug Far · NCT06395285Natural History Study of Usher Syndrome ( Light4Deaf )
Phase N/A · 4 location(s) · Centre Hospitalier National d'Ophtalmologie des Quinze-Vingt · NCT04665726National Ophthalmic Genotyping and Phenotyping Network (eyeGENE (Registered Trademark)), Stage 3 - Expansion of DNA and
Phase N/A · 2 location(s) · National Eye Institute (NEI) · NCT06491615Safety and Efficacy of 18 mm Short Vitrectomy Probe for Pediatric Vitreoretinal Surgeries
Phase 4 · 1 location(s) · Chang Gung Memorial Hospital · NCT06520410Micropulsed Laser in Patients With Macular Oedema in Retinal Dystrophies
NA · 1 location(s) · Fondazione G.B. Bietti, IRCCS · NCT05976139High-dose Topotecan for Retinoblastoma With Recurrent or Refractory Vitreous Seed
EARLY_Phase 1 · 1 location(s) · Eye & ENT Hospital of Fudan University · NCT06972602COmparison of Clarus and Optos Ultrawide Field Imaging Systems for Inherited Retinal Disease
NA · 1 location(s) · University of Wisconsin, Madison · NCT06380075Observational Study to Assess Endpoint Operational Feasibility & Measurement Properties in Patients with Retinal Degener
Phase N/A · 1 location(s) · Ray Therapeutics, Inc. · NCT06375239
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.